Clinical significance of increased gelatinolytic activity in the rectal mucosa during external beam radiation therapy of prostate cancer

被引:37
|
作者
Hovdenak, N
Wang, JR
Sung, CC
Kelly, T
Fajardo, LF
Hauer-Jensen, M
机构
[1] Bergen Univ Hosp, Dept Oncol, Bergen, Norway
[2] Univ Arkansas Med Sci, Dept Surg, Little Rock, AR 72205 USA
[3] Univ Arkansas Med Sci, Dept Pathol, Little Rock, AR 72205 USA
[4] Cent Arkansas Vet Healthcare Syst, Little Rock, AR USA
[5] Stanford Univ, Sch Med, Dept Pathol, Palo Alto, CA 94304 USA
[6] Vet Healthcare Syst, Palo Alto, CA USA
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2002年 / 53卷 / 04期
关键词
prostate cancer; radiation therapy; matrix metalloproteinases; rectum; inflammation;
D O I
10.1016/S0360-3016(02)02808-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Rectal toxicity (proctitis) is a dose-limiting factor in pelvic radiation therapy. Mucosal atrophy, i.e., net extracellular matrix degradation, is a prominent feature of radiation proctitis, but the underlying mechanisms are not known. We prospectively examined changes in matrix metalloproteinase (MMP)-2 and MMP-9 (gelatinase A and B) in the rectal mucosa during radiation therapy of prostate cancer, as well as the relationships of these changes with symptomatic, structural, and cellular evidence of radiation proctitis. Methods and Materials: Seventeen patients scheduled for external beam radiation therapy for prostate cancer were prospectively enrolled. Symptoms of gastrointestinal toxicity were recorded, and endoscopy with biopsy of the rectal mucosa was performed before radiation therapy, as well as 2 and 6 weeks into the treatment course. Radiation proctitis was assessed by endoscopic scoring, quantitative histology, and quantitative immunohistochemistry. MMP-2 and MMP-9 were localized immunohistochemically, and activities were determined by gelatin zymography. Results: Symptoms, endoscopic scores, histologic injury, and mucosal macrophages and neutrophils increased From-baseline to 2 weeks. Symptoms increased further from 2 weeks to 6 weeks, whereas endoscopic and cellular evidence of proctitis did not. Compared to pretreatment values, there was increased total gelatinolytic activity of MMP-2 and MMP-9 at 2 weeks (p = 0.02 and p = 0.004, respectively) and 6 weeks (P = 0.006 and p = 0.001, respectively). Active MMP-2 was increased at both time points (p = 0.0001 and p = 0.002). Increased MMP-9 and MMP-2 at 6 weeks was associated with radiation-induced diarrhea (p = 0.007 and p = 0.02, respectively) and with mucosal neutrophil infiltration (rho = 0.62). Conclusions: Pelvic radiation therapy causes increased MMP-2 and MMP-9 activity in the rectal mucosa. These changes correlate with radiation-induced diarrhea and granulocyte infiltration and may contribute to abnormal connective tissue remodeling in radiation proctitis. (C) 2002 Elsevier Science Inc.
引用
收藏
页码:919 / 927
页数:9
相关论文
共 50 条
  • [21] Evolution of definitive external beam radiation therapy in the treatment of prostate cancer
    Daly, Tiffany
    WORLD JOURNAL OF UROLOGY, 2020, 38 (03) : 565 - 591
  • [22] Evolution of definitive external beam radiation therapy in the treatment of prostate cancer
    Tiffany Daly
    World Journal of Urology, 2020, 38 : 565 - 591
  • [23] ADJUVANT EXTERNAL BEAM AND INTRAOPERATIVE RADIATION-THERAPY IN RECTAL-CANCER
    MINSKY, BD
    COHEN, AM
    CANCER INVESTIGATION, 1989, 7 (05) : 493 - 507
  • [24] Cigarette smoking during external beam radiation therapy for prostate cancer is associated with an increased risk of prostate cancer-specific mortality and treatment-related toxicity
    Steinberger, Emily
    Kollmeier, Marisa
    McBride, Sean
    Novak, Caroline
    Pei, Xin
    Zelefsky, Michael J.
    BJU INTERNATIONAL, 2015, 116 (04) : 596 - 603
  • [25] External beam radiation monotherapy for prostate cancer
    Akakura, K
    Furuya, Y
    Suzuki, H
    Komiya, A
    Ichikawa, T
    Igarashi, T
    Tanaka, M
    Murakami, S
    Ito, H
    INTERNATIONAL JOURNAL OF UROLOGY, 1999, 6 (08) : 408 - 413
  • [26] Probiotics for Rectal Volume Variation During Radiation Therapy for Prostate Cancer
    Ki, Yongkan
    Kim, Wontaek
    Nam, Jiho
    Kim, Donghyun
    Lee, Juhye
    Park, Dahl
    Jeon, Hosang
    Ha, Honggu
    Kim, Taenam
    Kim, Dongwon
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (04): : 646 - 650
  • [27] Secondary Cancer in Prostate Cancer Patients Treated With Advanced External Beam Radiation Therapy
    Kulkarni, Sarah E.
    Patel, Sagar A.
    Sun, Yuxian
    Jani, Ashesh B.
    Gillespie, Theresa W.
    McDonald, Mark W.
    Liu, Yuan
    INTERNATIONAL JOURNAL OF PARTICLE THERAPY, 2024, 13
  • [28] The prognostic significance of PSA at 6 months after external beam radiation for prostate cancer
    Mahadevan, A
    Reddy, CA
    Ciezki, J
    Kupelian, PA
    Klein, EA
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (01): : S459 - S460
  • [29] Integrating hormonal therapy with external-beam radiation and brachytherapy for prostate cancer
    Andrews, J
    Roach, M
    ONCOLOGY-NEW YORK, 2005, 19 (01): : 29 - 36
  • [30] PSA bounce phenomenon after external beam radiation therapy for prostate cancer
    Roszkowski, Krzysztof
    Makarewicz, Roman
    WSPOTCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2007, 11 (03): : 125 - 128